Industry Reports

Bristol-Myers Squibb Company (NYSE:BMY) has reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful...

SurModics Inc. a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry announced today that it will host a live webcast of its first quarter 2014 conference call on Thursday January 30 at 4:00...

The Reserve Bank of India (RBI) has sought clarity on whether foreign portfolio investments can be allowed in existing companies without government approval, putting the spotlight back on a sector that has been the subject of much debate and...

A report by PricewaterhouseCoopers For decades, the medtech industry was on the forefront of innovation, but now return on innovation investment is declining. Growth through technology innovation has slowed substantially and the benefits from incremental improvements to existing devices...

Bristol-Myers Squibb Company has reported results for the third quarter of 2013 highlighted by the strong performance of key marketed products such as Yervoy, Orencia and Sprycel, the presentation of important clinical data for its immuno-oncology pipeline, and the...

Abbott today announced financial results for the third quarter ended Sept. 30, 2013. Third-quarter 2013 worldwide sales of $5.4 billion increased 4.3 percent on an operational basis, with strong performance in Diagnostics and Medical Devices. ...

Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today its Q1 2013 revenues. Detail of the Q1 2013 revenues In thousands of euros...